Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas

Pediatr Dermatol. 2013 Sep-Oct;30(5):592-4. doi: 10.1111/pde.12209. Epub 2013 Jul 26.

Abstract

We report three cases of successful treatment of proliferating deep infantile hemangiomas with topical timolol 0.5% gel-forming solution (GFS) used two to three times daily. We recommend considering timolol as an initial option for small, deep facial hemangiomas that are not causing functional compromise or complications but may have an unsatisfactory cosmetic appearance. In our experience, albeit limited, this is a safe alternative to watchful waiting.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adrenergic beta-Antagonists / administration & dosage*
  • Facial Neoplasms / drug therapy*
  • Female
  • Gels
  • Hemangioma / drug therapy*
  • Humans
  • Infant
  • Male
  • Skin Neoplasms / drug therapy*
  • Timolol / administration & dosage*
  • Treatment Outcome
  • Watchful Waiting

Substances

  • Adrenergic beta-Antagonists
  • Gels
  • Timolol